Human Papillomavirus
Conditions
Keywords
HPV, HPV vaccination, knowledge of young
Brief summary
Today, cancers associated with papillomavirus infection affect 6,300 new people each year in France, men and women combined. The papillomavirus vaccine is currently the only vaccine that protects against HPV-associated cancers. However, in its report on vaccination coverage for 2024, Santé Publique France reveals that 41.5% and 37.4% of the 18- and 19-year-old French population respectively have a complete vaccination schedule. Information, education and communication about HPV are essential to enable the entire population to make informed and responsible decisions about HPV. Increasing information and immunization coverage for papillomavirus is part of the government's ambitious health plans with the national sexual health strategy and college vaccination campaign.
Detailed description
The main objective is to describe knowledge of girls and boys aged 18-19 about papillomavirus and HPV vaccination
Interventions
OTHERData collection
Data collection
Sponsors
Université de Reims Champagne-Ardenne
Study design
Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to 19 Years
Healthy volunteers
Yes
Inclusion criteria
Boys and girls 18 to 19 years of age Vaccinated or not against HPV Sexually active or not Agreeing to take part in the study
Exclusion criteria
Minors Age 20 and over Protected by law (guardianship, curatorship, safeguard of justice) Not wishing to answer the questionnaire
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Knowledge about HPV and anti-HPV vaccination | Day 0 | Knowledge about HPV and anti-HPV vaccination will be assessed by a questionnaire developed by a team of midwives and methodologists. Questions will address: Knowledge about HPV infection Knowledge of prevention measures Knowledge about HPV vaccination |
Countries
France
Outcome results
None listed